Meet Tracii Hutsona. “She can talk anybody into anything,” said her sister. Over decades, authorities say, she did.
Bobby Leonard, Hall of Fame Basketball Coach, Dies at 88
He coached the Indiana Pacers for 12 seasons and took them to three A.B.A. titles. The governor of Indiana called him “the embodiment of basketball.”
Pfizer defends high cost of COVID vaccine
The head of Pfizer said Thursday the company’s COVID vaccine, among the priciest on the market, is no more expensive than the cost of a meal and will not be sold to poor countries for a profit.
What to expect from Google I/O 2021
Google I/O is back as a virtual event and free to everyone who wants to attend.
Scientists create embryos with cells from monkeys, humans
Researchers have successfully introduced human stem cells into monkey embryos in the lab, creating short-lived hybrid organisms that could prove an important step in growing human transplant organs from livestock or creating better animal models for studying human disease.
Covax seeks $2 bn donations to cover COVID vaccines
The Covax scheme launched a push for an extra $2 billion in donations on Thursday, saying it needed the money in advance to reserve COVID-19 vaccine doses.
France’s COVID-19 deaths pass 100,000
The number of people killed by COVID-19 in France climbed past 100,000 on Thursday, with the virus claiming a further 300 lives in the past 24 hours, the country’s health authority said.
Israel to scrap outdoor mask mandate from Sunday
Israelis will no longer have to wear masks outdoors starting from Sunday as the number of virus infections plummets, Health Minister Yuli Edelstein said.
Study suggests those who had COVID-19 may only need one vaccine dose
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient …
Study: New approach may boost prostate cancer immunotherapies
Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body’s immune cells fight the cancer. The discovery, made in human and mouse cells and in laboratory mice, could lead to improvements in immunotherapy treatments for prostate cancer, the second most common cancer in men in the US.